Patterns of chlamydia testing in different settings and implications for wider STI diagnosis and care: a probability sample survey of the British population

Soazig Clifton, Catherine H Mercer, Sarah C Woodhall, Pam Sonnenberg, Nigel Field, Le Lü, Margaret Johnson, Jackie CassellSexually 2016 · DOI

TL;DR

This study reveals that most chlamydia testing in Britain now happens outside of specialized genitourinary medicine (GUM) clinics, primarily in general practices and other community settings. While this increases accessibility, it raises concerns about potentially missed opportunities for diagnosing other sexually transmitted infections (STIs), particularly among a significant minority of individuals who engage in higher-risk behaviors but are not being referred for comprehensive STI care.

What Problem Does This Paper Address?

The widespread rollout of chlamydia testing in the UK has aimed to increase screening, especially among younger populations. However, a key challenge has emerged: many individuals are tested for chlamydia in non-specialist settings (like general practice) without a comprehensive assessment for other STIs, including HIV. This raises a critical question: are these expanded testing sites effectively integrated into a broader sexual health care system, or are they creating missed opportunities for early diagnosis and treatment of other infections? The paper seeks to understand the characteristics of individuals testing in different settings and their implications for broader STI diagnosis and care.

Methods

The researchers utilized data from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3), a large-scale, probability sample survey conducted in Britain between 2010 and 2012. This survey involved in-person and self-completion questionnaires to gather detailed information on sexual behavior, testing history, and diagnoses. The study focused on a subset of participants aged 16-44 who reported at least one sexual partner in the past year. Statistical analysis involved weighted data to account for survey design and non-response bias. Multinomial regression was employed to compare demographic and behavioral characteristics of individuals tested in genitourinary medicine (GUM) clinics versus those tested in general practice (GP) or other non-GUM settings.

Datasets

The primary dataset used in this study is the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3), a probability sample survey of the British population conducted between 2010 and 2012. This dataset is a nationally representative survey of sexual attitudes and lifestyles. No new datasets were introduced.

Key Insights and Ideas

  • Decentralization of Chlamydia Testing: The most striking finding is the shift of chlamydia testing away from specialized GUM clinics towards more accessible settings like GPs and other community services. This suggests a significant change in how sexual health services are being accessed.
  • "Lower Risk" Populations in Non-GUM Settings: Individuals testing in GP and other non-GUM settings generally report fewer traditional STI risk behaviors (e.g., fewer partners, less concurrency). This might explain why these settings are increasingly used for chlamydia screening, as they may be perceived as less intimidating.
  • The "Sizeable Minority" at Risk: Despite the general trend of lower-risk individuals in non-GUM settings, a significant proportion still report behaviors that place them at higher risk for other STIs (e.g., unsafe sex). This highlights a critical gap in care.
  • Missed Opportunities for Broader STI Screening: A substantial number of individuals treated for chlamydia outside GUM settings did not report an HIV test in the same timeframe, despite national recommendations for comprehensive STI testing. This points to a potential failure in integrated sexual health care.
  • Specific Concerns for MSM: A small but notable proportion of men who tested for chlamydia outside GUM reported sex with men, with limited evidence of concurrent HIV testing or attendance at GUM clinics. This suggests a particular vulnerability for this group within non-specialist settings.

Key Results

  • Testing Locations: For women aged 16-44, 41.1% tested in GP and 30.5% in other non-GUM settings, compared to 28.4% in GUM. For men, 41.2% tested in GUM, 20.7% in GP, and 37.7% in other non-GUM settings.
  • Risk Behaviors: Individuals tested in GP or other non-GUM settings generally reported fewer sexual partners and less concurrency compared to those tested in GUM.
  • Unsafe Sex: Despite lower overall risk, 11.0% of women tested in GP and 13.2% in other non-GUM settings reported "unsafe sex" (defined as two or more partners and no condom use). For men, these figures were 6.8% (GP) and 9.6% (other non-GUM settings).
  • HIV Testing: A significantly lower proportion of individuals treated for chlamydia outside GUM reported an HIV test in the past 5 years compared to those treated in GUM. For women, this was 54.5% vs. 74.1%, and for men, 23.9% vs. 65.8%.

Limitations and Future Work

The authors acknowledge several limitations:

  • Self-Reported Data: The reliance on self-reported data means that recall and reporting biases could influence the findings.
  • Most Recent Test Only: The study only captured the location of the most recent chlamydia test, which might not reflect the full picture of an individual's testing history if they were tested multiple times.
  • Sample Size Constraints: Small sample sizes limited the ability to conduct detailed analyses for specific subgroups, such as by ethnicity or for men who have sex with men (MSM) tested outside GUM.
  • Causality: The study design does not allow for definitive causal conclusions; for instance, it's possible that HIV testing was unrelated to the chlamydia diagnosis.
  • Time Sequence: The exact timing of events (e.g., chlamydia diagnosis vs. HIV test) is not always clear, making it difficult to establish direct links.

Future work could focus on:

  • Improving Integration: Developing clearer pathways for comprehensive STI care within non-GUM settings.
  • Targeted Interventions: Designing specific interventions for individuals who report higher-risk behaviors in non-GUM settings.
  • Understanding Declines: Investigating why individuals might decline HIV testing when offered in non-GUM settings.
  • Longitudinal Studies: Conducting studies that track individuals over time to better understand testing patterns and outcomes.
  • Addressing Inequalities: Further research into how testing venue relates to known inequalities in STI incidence, particularly for HIV.

Summary updated

Abstract

Most chlamydia testing occurred in non-GUM settings, among populations reporting fewer risk behaviours. However, there is a need to provide pathways to comprehensive STI care to the sizeable minority at higher risk.
BibTeX
@inproceedings{clifton2016patterns,
  author = {Soazig Clifton and Catherine H Mercer and Sarah C Woodhall and Pam Sonnenberg and Nigel Field and Le Lü and Margaret Johnson and Jackie Cassell},
  title = {{Patterns of chlamydia testing in different settings and implications for wider STI diagnosis and care: a probability sample survey of the British population}},
  booktitle = {Sexually},
  year = {2016},
  doi = {10.1136/sextrans-2016-052719},
}
Figure